More than half of patients that undergo cancer treatment are estimated to have had at least one potential drug-drug interaction.…
Browsing: Other
The increased use of targeted therapies in oncology has introduced a range of new side effects. Emma Foreman, BPharma (Hons)…
Dr. Nathan Pennell, Cleveland Clinic, discusses acquired resistance to Xalkori in ALK-positive patients, and second generation inhibitors designed to overcome…
Dr. Nathan Pennell, Cleveland Clinic, evaluates chemotherapy sensitivity assays, describing the difficulties inherent in predicting response to chemotherapy agents.
Dr. Gerard Silvestri, Medical University of South Carolina, describes some of the typical presenting symptoms of lung cancer.
GRACE – Global Resource for Advancing Cancer Education Published on Feb 24, 2016 Dr. Gerard Silvestri, Medical University of South…
Dr. Gerard Silvestri, Medical University of South Carolina, discusses the use of PET scans in lung cancer workup.
With the the field of molecular diagnostics rapidly advancing, the demand for prognostic and diagnostic molecular information on myelodysplastic syndrome…
Torsten Haferlach, MD, PhD, of the Munich Leukaemia laboratory, Munich, Germany, highlights the rapidly expanding field of molecular diagnostics, moving…
Knowledge of the molecular background of myelodysplastic syndrome (MDS) has been greatly advanced by developments in techniques such as next-generation…
In this video, Steven Pavletic, MD, MS, from the National Cancer Institute, Bethesda, MD, speaks at the European Society for…
From the European Society for Blood and Marrow Transplantation (EBMT) 2018 Annual Meeting, held in Lisbon, Portugal, Steven Pavletic, MD,…
Steven Pavletic, MD, MS, from the National Cancer Institute, Bethesda, MD, gives an overview of the management of chronic graft-versus-host…
Treating aplastic anemia (AA) with transplantation in a pediatric population is deemed relatively complicated, according to Régis Peffault de Latour,…
Régis Peffault de Latour, MD, PhD, from Saint Louis Hospital, Paris, France, discusses the main challenges in managing patients with…
From the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting, held in Lisbon, Portugal, Régis Peffault de…
Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Denis Claude Roy,…
Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Matti Aapro, MD, of the Clinique de…
New lung cancer therapies are constantly being developed and approved. Indeed, the new treatments on the market have rendered chemotherapy…
Decreasing tobacco intake is a key goal for reducing the incidence of lung cancer. In this video, recorded at the…
Lung cancer screening is an exciting and debated topic. Here, Mamta Ruparel, MBBS, MRCP, of University College London, London, UK,…
Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Christine Walko, PharmD, BCOP, FCCP, of…
In this interview, David DeRemer, PharmD, BCOP, FCCP, of the University of Florida, Gainesville, FL, discusses mid-career changes that pharmacists…
In this interview, Christine Walko, PharmD, BCOP, FCCP, of the Moffitt Cancer Center, Tampa, FL, speaks about the Moffitt Cancer…
In this interview, Amy Pick, PharmD, BCOP, of Creighton University, Omaha, NE, speaks about different types of stressors for mid-career…
Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference held in Denver, CO, Amy Pick, PharmD, BCOP, of Creighton…
Clinical trials are designed to test the effect of new drugs and treatments in a highly controlled environment. While this…
The field of genomics is one of great promise, and there is hope that it can be implemented into all…
Checkpoint inhibitors are an exciting therapy across a range of cancer types. Speaking from the American Society of Oncology (ASCO)…
There have previously been no randomized trials assessing systemic therapy activity for progressive desmoid tumors. Here, Maud Toulmonde, MD, of…
Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, evaluates a variety of particular systemic treatment agents for possible use in…
Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, describes the types of situations in which local therapy is appropriate for…
The purpose of the iNNOVATE study (NCT02165397) was to evaluate the safety and efficacy of ibrutinib and rituximab for the…
Social media has become increasingly relevant in the field of healthcare, both from the perspective of patients seeking the newest…
Iron-deficiency anemia is an extremely common form of anemia. Here, Maria Domenica Cappellini, MD, of the University of Milan-Foundation IRCCS…
There are several genetic instruments available to measure the impact of Gaucher Disease (GD) on a patients quality of life,…
Thalassemia is caused by defects in either ? or ? globin chains, which are required for formation of functional hemoglobin…
Treatments for low-risk myelodysplastic syndromes (MDS) cannot cure the disease, but rather aim to improve quality of life, reduce complications…
Idiopathic thrombocytopenic purpura or immune thrombocytopenia (ITP) is a disorder which may result in excessive bleeding or bruising due to…
Blastic plasmocytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy typically associated with poor patient outcomes. Naveen Pemmaraju, MD,…
Transfusion-dependent thalassemia demands regular and time-consuming treatment, with patients requiring blood transfusions every few weeks, and for the iron that…
Acquired von Willebrand disease is a rare condition that has been reported in post-autologous bone marrow transplant (BMT) patients, though…
Aplastic anemia (AA) results in T-cells attacking bone marrow stem cells, causing loss of all blood cell types. Generally, this…
Gaucher disease (GD) is a rare genetic disorder which is seldom diagnosed because of its rarity, although diagnoses can be…
Speaking from the British Society for Hematology (BSH) 2018 Annual Scientific Meeting in Liverpool, UK, Derralyn Hughes, MA, DPhil, FRCP,…
Sonja Hoy, BS, PGDip, of The Royal Marsden NHS Foundation Trust, London, UK, discusses the importance of good oral hygiene…
GRACE is happy to present the 6th video in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches…
In this seventh video from the Targeted Therapy in Lung Cancer Live Patient Forum Webcast series, GRACE presents the lunchtime…
In this ninth video from the Targeted Therapy in Lung Cancer Live Patient Forum Webcast series, GRACE presents the afternoon…
During the Targeted Therapies in Lung Cancer Patient Forum, many of our fantastic and loved attendees shared with us what…